Jul 20, 2026 07:30AM
Jul 9, 2026 05:01PM
Jul 9, 2026 05:00PM
Jun 29, 2026 07:31AM
Jun 29, 2026 07:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM Biohaven Reports First-in-Human Dosing of Oral PKM2 Modulator, BHV-8100, Targeting Metabolic Restoration and Immunomodulation
May 27, 2026 07:31AM
May 27, 2026 07:30AM
May 26, 2026 07:31AM
May 26, 2026 07:30AM
May 4, 2026 04:02PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM Biohaven's Phase 2 Obesity Study with Taldefgrobep Alfa, a Novel Myostatin-Activin Pathway Inhibitor, Completes Enrollment
Mar 2, 2026 04:05PM
Feb 23, 2026 08:43AM
Jan 12, 2026 11:20AM
Jan 12, 2026 11:15AM
Jan 7, 2026 07:00AM
Dec 24, 2025 01:00PM
Dec 24, 2025 01:00PM Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder
Dec 11, 2025 07:02AM
Dec 11, 2025 07:00AM
Nov 17, 2025 07:38AM
Nov 11, 2025 04:29AM
Nov 10, 2025 06:58AM
Nov 6, 2025 08:37AM
Nov 5, 2025 04:09PM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $15 at Leerink Partners
Nov 5, 2025 03:33PM
Nov 5, 2025 10:00AM
Nov 5, 2025 08:20AM
Nov 5, 2025 08:19AM
Nov 5, 2025 08:17AM
Nov 5, 2025 08:16AM
Nov 5, 2025 06:10AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $42 at Baird
Nov 5, 2025 01:56AM
Nov 4, 2025 08:06PM
Nov 3, 2025 10:00AM
Nov 3, 2025 09:24AM
Sep 10, 2025 09:16AM
Aug 30, 2025 04:00PM
Aug 22, 2025 07:04AM Biohaven receives FDA update on troriluzole drug application
Aug 19, 2025 05:05AM
Aug 12, 2025 06:41AM
Aug 11, 2025 07:00AM
Jul 22, 2025 05:52PM
Jul 20, 2025 10:50AM
Jun 28, 2025 10:00AM
Jun 23, 2025 12:47PM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN
Jun 18, 2025 12:21PM

326,424 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All